Okay, let's tackle this question about calcitonin's primary effect. First, I need to recall what calcitonin does. I remember it's a hormone related to calcium regulation. The main players in calcium are parathyroid hormone (PTH) and calcitonin. PTH increases blood calcium by stimulating bone resorption and increasing calcium reabsorption in the kidneys. But calcitonin is the opposite, right? It lowers blood calcium levels.

So the question is asking for the primary effect. The options might include things like increasing bone resorption, decreasing bone resorption, increasing renal excretion of calcium, or maybe something else. Let's think about the mechanisms. Calcitonin inhibits osteoclast activity, which are the cells that break down bone and release calcium. When osteoclasts are inhibited, less calcium is released into the blood, thus lowering serum calcium levels. This is the main action compared to other effects.

Now, the wrong options: If one option says it increases bone resorption, that's PTH's job. Another might say it increases calcium absorption in the intestines, which is vitamin D's role. Another could be about the kidneys, like increasing excretion, but I think calcitonin's primary effect is on the bones, not the kidneys. Wait, does calcitonin affect the kidneys? Maybe slightly, but the main effect is on osteoclasts.

Clinical pearl: Remember that calcitonin is used for hypercalcemia and osteoporosis, but its use is less compared to bisphosphonates. Also, it's a key hormone in calcium homeostasis, opposing PTH. High-yield fact: Calcitonin inhibits osteoclast activity, decreasing serum calcium. That's the main point for the exam.

**Core Concept**
Calcitonin is a hormone secreted by the thyroid C-cells that regulates calcium homeostasis. Its primary action is to **decrease serum calcium levels** by inhibiting osteoclast-mediated bone resorption, opposing the effects of parathyroid hormone (PTH).

**Why the Correct Answer is Right**
Calcitonin binds to calcitonin receptors on osteoclasts, inhibiting their activity and reducing the breakdown of bone matrix. This decreases the release of calcium and phosphate into the bloodstream. While it has minor effects on renal calcium excretion, its **primary and most rapid action** is on bone. This is critical in acute hypercalcemia management and in conditions like Paget’s disease.

**Why Each Wrong Option is Incorrect**
**Option A:** *Increases serum calcium* – Incorrect. Calcitonin lowers serum calcium; this is the action of PTH.
**Option B:** *Enhances intestinal calcium absorption* – Incorrect. This is mediated by active vitamin D (calcitriol), not calcitonin.
**Option D:** *Promotes renal calcium reabsorption* – Incorrect. Calcitonin may slightly reduce renal calcium reabsorption, but this is not its primary mechanism.

**Clinical Pearl / High-Yield Fact**
Calcitonin is a **first-line agent for acute hypercalcemia** (e.g., in cancer patients) due to its rapid onset. However, long-term use is limited by tachyphylaxis. Remember: *Calcitonin = "Calcium down, bone up!"* (inhibits calcium

✓ Correct Answer: A. Bone deposition